United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 18, 2026 · Filed May 19, 2026

On May 18, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$567.04 for US$5.39M under a trading plan, leaving 40,513 shares. Filed May 19, 2026 (Form 4).

Sold
9,500 shares
Price
US$567.04 average (US$563.01 to US$569.99)
Value
US$5.39M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 18, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 18, 2026Common StockSale133US$563.0149,880Direct
May 18, 2026Common StockSale365US$564.1149,515Direct
May 18, 2026Common StockSale1,811US$565.3447,704Direct
May 18, 2026Common StockSale2,117US$566.3345,587Direct
May 18, 2026Common StockSale2,280US$567.4543,307Direct
May 18, 2026Common StockSale1,437US$568.3341,870Direct
May 18, 2026Common StockSale1,077US$569.4240,793Direct
May 18, 2026Common StockSale280US$569.9940,513Direct

Source

View original at SEC

Related